𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comment on the use of the cre/loxP recombinase system for gene therapy vectors

✍ Scribed by Scott, S D; Marples, B

Book ID
110038793
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
63 KB
Volume
7
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inactivation of the murine Transferrin R
Inactivation of the murine Transferrin Receptor 2 gene using the Cre recombinase: LoxP system
✍ Daniel F. Wallace; Ian D. Tonks; Anna Zournazi; Graham F. Kay; V. Nathan Subrama πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views

## Abstract Summary: Transferrin Receptor 2 (TfR2) is a key molecule involved in the regulation of iron homeostasis. Mutations in TfR2 lead to type 3 hemochromatosis in humans. We have developed mice with a targeted deletion of TfR2. The Cre‐recombinase:__lox__P system used to create the mice allow

Gene therapy utilizing the Cre/loxP syst
Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells
✍ Hiroyuki Goto; Tadashi Osaki; Takashi Kijima; Kazumi Nishino; Toru Kumagai; Tosh πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 662 KB

Recent clinical trials of cancer gene therapy have shown encouraging results for controlling localized tumors. However, to control metastatic or disseminated tumor cells, further modification of vectors is required to enhance specificity and infectivity against targets. We investigated whether utili